Allergan Sales, LLC has recalled approximately 868,657 bottles of prescription eye medications, specifically Combigan (brimonidine tartrate/timolol maleate) and Lumigan (bimatoprost). The recall was initiated because the products failed to meet required specifications for impurities and degradation during testing. Consumers should contact their healthcare provider or pharmacist regarding their medication and return any unused portions of the affected lots to their pharmacy for a refund.
The presence of impurities or degradation products beyond approved limits can reduce the effectiveness of the medication or potentially cause unexpected side effects during use. No specific injuries or adverse events have been reported in the current data, but the products no longer meet the quality standards required for patient safety.
Drug recall refund and consultation
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.